Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00139295
NCT00139295CompletedPhase 3

Comparison of the Efficacy and Safety of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee

Genzyme, a Sanofi Company48 sites in 5 countriesStarted: October 1, 2004Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Locations
48
Primary Endpoint
pain relief
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This is a clinical study to investigate the safety and efficacy of hylastan in treating patients with symptomatic osteoarthritis (OA) of the knee.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double

Eligibility Criteria

Ages
40 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosed with OA of the knee
  • •Have tried but not been sufficiently helped by conservative treatment, such as weight reduction and pain medications

Exclusion Criteria

  • •Prior or concomitant treatments that would impede measurement of safety and efficacy

Outcomes

Primary Outcomes

pain relief

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Genzyme, a Sanofi Company
Sponsor Class
Industry

Study Sites (48)

Loading locations...

Similar Trials

Unknown
Not Applicable
Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic CystitisHemorrhagic Cystitis
NCT04696666LIDDE Therapeutics30
Completed
Not Applicable
TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in BelgiumHypertension
NCT00886288Boehringer Ingelheim2,874
Completed
Phase 4
Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionHypertension
NCT01012479Takeda107
Withdrawn
Phase 1
Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver DiseaseFatty Liver, Nonalcoholic
NCT04761848Sadat City University120
Completed
Not Applicable
Restylane® for the Treatment of Tear Trough DeformityTear Trough Eyelid Deformity
NCT04486794Erevna Innovations Inc.42
Comparison of Hylastan to... | Clinical Trial